Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: A case report

1Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

We report a 31-year-old woman with tumor-induced osteomalacia suffering from slowly progressive bilateral muscle weakness predominantly in the proximal muscles and multiple bone pains for the past 2 years. She was unable to walk or raise her arms above the shoulder. We suspected tumor-induced osteomalacia due to decreased serum phosphate and 1α, 25 (OH)2-vitamin D3 levels, low percentage of tubular reabsorption of phosphate (%TRP), adult onset, and no family history of osteomalacia. Regular imaging examinations could not detect the location of the primary tumor: however, indium-111 octreotide scintigraphy detected the causative primary mesenchymal tumor in the right sole. Pain and muscle weakness improved promptly after tumor resection, and she was able to walk 6 d postoperatively. This is the first case report in Japan describing the detection of the primary tumor site by indium-111 octreotide scintigraphy.

Cite

CITATION STYLE

APA

Takahashi, M., Toru, S., Ota, K., Izumiyama, H., Yokota, T., & Mizusawa, H. (2008). Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: A case report. Clinical Neurology, 48(2), 120–124. https://doi.org/10.5692/clinicalneurol.48.120

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free